Next Investors Apr 21, 2022
Our biotech investment, Arovella Therapeutics (ASX:ALA), is one of only a handful of companies in the world working on an iNKT cell therapy for cancer.
Finfeed Archived Apr 17, 2020
PharmAust Limited (ASX: PAA) has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research (WEHI) to test the effects of monepantel (MPL) on COVID-19 infections.
Finfeed Archived Apr 01, 2020
ImpediMed Limited (ASX: IPD) has received the first order of 16 units under the recently announced national purchasing agreement with a US oncology care network for its SOZO® Digital Health Platform and Lymphoedema Prevention Program.
Get expert stock analysis direct in your inbox
Join OurMailing List
Get Expert StockAnalysis and Opinions
Join thousands of other Investors following our stock commentary for Free